Therapeutic angiogenesis is an attractive strategy to treat patients suffering from peripheral or coronary artery disease. VEGF (vascular endothelial growth factor-A) is the fundamental factor controlling vascular growth in both development and postnatal life. The interplay between the VEGF and Notch signalling pathway has been recently found to regulate the morphogenic events leading to the growth of new vessels by sprouting. Angiogenesis can also take place by an alternative process, i.e. intussusception or vascular splitting. However, little is known about its role in therapeutic angiogenesis and its molecular regulation. In the present article, we briefly review how VEGF dose determines the induction of normal or aberrant angiogenesis and the molecular regulation of sprouting angiogenesis by Notch signalling, and compare this process with intussusception.
To sprout or to split? VEGF, Notch and vascular morphogenesis
Introduction VEGF (vascular endothelial growth factor-A) is the master regulator of angiogenesis both in physiological development and in disease [1] and is capable of starting the complex cascade of events leading to endothelial cell activation, assembly of new vascular structures, mural cell recruitment and vessel stabilization. For these reasons, VEGF is the primary target of therapeutic approaches aiming to restore the blood supply to ischaemic tissues. However, over the last few years, it has become clear that the physiological induction of normal and functional blood vessels is critically dependent on both how much VEGF is delivered, i.e. its dose, as well as on how the factor is presented to endothelial cells, i.e. the formation of gradients in vivo. The Notch signalling pathway has recently been found to be responsible for integrating this spatiotemporal information into morphogenic events leading to the sprouting of new vascular networks. On the other hand, vascular growth can take place also by a different, and much less well-characterized, process, i.e. intussusception, or splitting angiogenesis. In the present brief review, we summarize how VEGF and Notch signalling regulate sprouting angiogenesis and compare this process with intussusception.
VEGF dose: total compared with microenvironmental
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severely compromised the formation of blood vessels, causing embryonic lethality [2, 3] . On the other hand, a modest 2-3-fold increase in VEGF expression also caused severe abnormalities and resulted in embryonic death [4] . Furthermore, uncontrolled VEGF overexpression has deleterious effects also in adult tissues, such as severe oedema and the growth of vascular tumours [5] [6] [7] [8] . These studies, together with the results of VEGF gene therapy clinical trials, which have shown good safety, but disappointing efficacy [9] , suggest that VEGF delivery appears to have a very limited therapeutic window in vivo, such that low doses are safe, but mostly inefficient, and higher doses become rapidly unsafe.
However, taking advantage of a unique myoblast-based gene-delivery platform, we found that VEGF can induce either normal or aberrant angiogenesis depending on its amount in the microenvironment around each producing cell, and not on the total dose delivered. In fact, VEGF remains bound to the extracellular matrix and different levels do not average with each other in the tissue [10] . Since retroviruses randomly integrate in the genome, a population of transduced myoblasts expresses a wide range of VEGF levels in different cells. However, by isolating clonal populations, in which every cell expressed the same VEGF amount, it was possible to investigate the effects of specific microenvironmental doses. As shown in Figure 1 , when expression was heterogeneous, angioma-like vascular structures were always induced, despite severalfold reductions in total dose down to 5 ng/10 6 cells/day. On the other hand, homogeneous expression by the clonal populations revealed that a wide range of microenvironmental VEGF levels, up to ∼70 ng/10 6 cells/day, induced only normal and functional capillaries, whereas angiomas were caused only by levels above this threshold [10] . Furthermore, the distribution of expression levels in the tissue has functional consequences. In fact, in a murine model of hindlimb ischaemia, the heterogeneous population, expressing an average VEGF level of 60 ng/10 cells/day, was ineffective in increasing blood flow, whereas blood flow was fully restored to non-ischaemic levels and collateral arteriogenesis was induced when the same total dose was uniformly distributed in muscle by implanting a clonal population [11] .
VEGF gradients in vivo
Several studies have shown that the spatial distribution of VEGF within the microenvironment, i.e. the formation of tissue gradients and their shape, has a fundamental role in regulating normal vascular growth.
The importance of VEGF gradients in directing the formation of new capillaries has been elegantly shown in the vascularization of the newborn mouse retina [12] . In this model, it was shown that extracellular VEGF gradients stimulate and guide specialized processes, called filopodia, from the endothelial cell at the tip of new vascular sprouts. These cells, named tip cells, do not form a lumen and do not proliferate, but rather they sense the VEGF gradient and move towards it, leading the growing sprout. In contrast, endothelial cells behind the tip, called stalk cells, proliferate and are responsible for the formation of the new lumenized vessel (Figures 2A and 2B ). Whereas tip cells respond exclusively to the VEGF gradient, stalk cells are regulated by its absolute concentration [12] . The influence of the shape of VEGF gradients on the morphology of induced vessels has been investigated by taking advantage of the different properties of VEGF isoforms [13] . The VEGF molecule exists in three major isoforms, constituted by 120, 164 and 188 amino acids respectively in the mouse (121, 165 and 189 in humans), generated by alternative splicing. They differ from each other in the size of the heparin-binding domain. In fact, whereas VEGF 120 lacks this domain completely and is therefore soluble, VEGF 164 and VEGF 188 display increasing affinity for extracellular matrix with increasing size and remain more localized in the microenvironment around producing cells [14] . Genetic manipulation of each of these isoforms in the mouse hindbrain and in the retina revealed that in mutants expressing only VEGF 120 , angiogenesis was impaired, the number of filopodia was significantly reduced and their orientation was compromised, resulting in vascular networks with reduced branching and increased capillary diameter [13] . This phenotype was caused by a lack of sprouting, with preferential integration of endothelial cells into existing vessels, and correlated with a disruption of 164 , also displayed a normal vessel morphogenesis, similar to the effects of VEGF 164 alone [13] . Taken together, these findings emphasize that a balanced production of soluble and matrix-binding isoforms is essential for the establishment of a directional VEGF gradient around each cell. Spatial distribution is a fundamental factor to determine between directional sprouting through tip cell migration and circumferential enlargement through nondirectional endothelial proliferation.
Notch signalling in VEGF-induced sprouting angiogenesis
It has recently been found that the Notch signalling pathway is responsible for the integration of the spatiotemporal cues provided by VEGF gradients in the orderly process of sprouting. The Notch pathway is evolutionarily conserved among species [15] . Both Notch receptors and the ligand families Dll (Delta-like) and Jag (Jagged) are transmembrane molecules. In vertebrates, there are four Notch receptors, Notch1-Notch4, and five single-pass transmembrane canonical ligands: Dll1, Dll3, Dll4, Jag1 and Jag2 [16] . Upon cellcell contact and ligand binding, Notch receptors undergo two proteolytic cleavages. The first cleavage occurs in the extracellular domain and is operated by proteases of the ADAM (a disintegrin and metalloproteinase)/TACE [TNFα (tumour necrosis factor α)-converting enzyme] family. As a result, a conformational change takes place that makes a second cleavage possible by γ -secretase, upon which the intracellular domain is released. Whereas the extracellular domain remains bound to the ligand and is degraded by the ligand-expressing cells after endocytosis, the intracellular domain translocates to the nucleus where it activates the expression of target genes [16] .
In particular, signalling between Dll4 and Notch1 has been shown to regulate the formation of appropriate numbers of tip cells by VEGF and to control vessel sprouting. VEGF induces Dll4 expression on endothelial cells [17, 18] . Both pharmacological inhibition of Notch signalling by γ -secretase inhibitors and disruption of Dll4 expression by genetic means or protein knockdown have been shown to increase tip cell formation and sprouting [19] [20] [21] [22] . Conversely, ectopic activation of Notch signalling by administration of soluble Jag1 peptide led to a reduction in tip cell formation and filopodia extension, resulting in reduced vascular density [19] . Blockade of Dll4-Notch signalling by systemic administration of Dll4-neutralizing antibodies [23, 24] or modified Dll4 proteins [23, 25] has been found to promote endothelial sprouting and increase vascular density also in tumour models in mice. However, the increased sprouting was non-productive and the increased vascularity paradoxically led to reduced perfusion, increased hypoxia and decreased tumour growth [23] . Recently, it has been also demonstrated that endothelial cells compete dynamically for the tip cell position during angiogenic sprouting by changing their relative expression of VEGF receptor-1 and VEGF receptor-2 [26] . Collectively, these data support a model in which the first endothelial cell to react to a VEGF gradient becomes a tip cell and, by up-regulating Dll4, activates Notch signalling in the neighbouring cells, which are inhibited from becoming tip cells and assume the stalk cell phenotype instead.
Intussusceptive angiogenesis
A growing body of literature shows that angiogenesis does not occur exclusively by sprouting, but also through an alternative process called intussusception, or splitting angiogenesis. In intussusception, endothelial processes protrude into the vascular lumen from the opposing walls. Upon contact between these processes, a transluminal pillar is formed, which is subsequently invaded by supporting cells, i.e. pericytes and fibroblasts, with deposition of matrix [27] . As the pillar increases in girth, it splits the vascular segment into two independent new vessels, hence the alternative nomenclature of splitting angiogenesis ( Figures 2C and 2D ).
Intussusception and sprouting are two complementary processes. In the developing chicken lung, the basic pattern of supplying and draining vessels is established by sprouting, whereas the final expansion and maturation of the vasculature takes place through intussusception [28] . In the chick CAM (chorioallantoic membrane), blood vessels grow initially by sprouting and then mainly by intussusception [29] . Also in mammalian organisms, e.g. during rat pregnancy, the mammary vasculature initially grows by sprouting, followed by intussusception [30] .
Intussusception can be driven by blood flow. In the CAM, splitting has been described during vascular adaption to increased blood flow [31] . Furthermore, it has been reported that muscle capillary growth as a consequence of increased blood flow occurs through intraluminal splitting and in the absence of sprouting [32] . Intussusception has also been described in pathological conditions such as tumour angiogenesis, where it has been found that, after antiangiogenic treatments or radiotherapy, tumours can rapidly recover by switching from sprouting to intussusceptive vessel growth [33] . However, the molecular mechanisms of intussusception are poorly understood. VEGF signalling has been found to be necessary for shear stress-dependent splitting of capillaries in skeletal muscle [34, 35] , and it has been proved that VEGF is able to directly promote intussusception in the CAM [36] . Furthermore, we have found recently that also therapeutic overexpression of different VEGF doses in skeletal muscle induces new vascular networks by a first stage of vessel enlargement followed by intussusceptive remodeling (R. Gianni-Barrera, M. Trani, R. Hluschchuk, M. Heberer, V. Djonov and A. Banfi, unpublished work).
A role of Notch signalling in intussusception?
Sprouting angiogenesis relies on the generation of an alternate 'salt and pepper' pattern of Notch1 activation in neighbouring endothelial cells, which leads to a balanced formation of tip and stalk cells. A recent computational model based on the current experimental evidence has shown that both VEGF concentration and VEGF gradients are critical parameters involved in the determination of a balanced number of tip and stalk cells [37] . In this computational simulation of notchmediated tip cell selection, the increased tip cell selection rate in the presence of a VEGF gradient is attributed to filopodia extension. In fact, subtle differences in filopodia length may be translated into different VEGF receptor activation rates. The simulation predicted further that only a narrow range of VEGF concentrations is able to guarantee a correct balance between the tip and stalk phenotypes, whereas high VEGF levels would generate an oscillating negative-feedback loop, which would disrupt the balance and induce an all-stalk or an all-tip phenotype [37] . An all-stalk phenotype is expected to lead to circumferential enlargement of the vessels without sprouting, which constitutes the first stage of intussusception. It is tempting to speculate that alternative patterns of Notch activation, leading to either proper tip cell induction or to their absence as a consequence of, for example, different VEGF doses and shapes of its gradient, could determine the morphogenic decision to undergo sprouting rather than splitting, or vice versa. Is Notch the gatekeeper of these processes? Careful experiments in highly controlled models of time-and dose-dependent VEGF overexpression will be necessary to verify this hypothesis.
